Andere Sprachen T2 Biosystems, Inc.

Aktien

A3EU63

US89853L3024

TTOO

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 03.05.2024			% 5 Tage	% 1. Jan.
3,72 ^USD	+1,92 %		+30,99 %	-40,72 %

29.04.	T2 BIOSYSTEMS, INC. : Canaccord Genuity bekräftigt seine neutrale Bewertung	ZM
01.04.	T2 Biosystems, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024	24.04.
Top Premarket Decliners	23.04.
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity	11.04.
T2 Biosystems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01.04.
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.	28.03.
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc	28.03.
T2 Biosystems, Inc. Reiterates Revenue Guidance for the Year 2024	20.03.
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates	20.03.
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates	20.03.
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates	19.03.
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel	18.03.
T2 Biosystems, Inc. Announces Publication of New Study Highlighting Clinical Benefits and Performance of Real-World Use of T2Resistance Panel in Journal of Clinical Microbiology	18.03.
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement	12.03.
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results	15.02.
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity	15.02.
T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia	15.02.
T2 Biosystems, Inc. Announces Commercial Expansion Through Distributors in Europe and Asia	15.02.
Sector Update: Health Care Stocks Mixed Late Afternoon	12.02.
Sector Update: Health Care Stocks Steady in Afternoon Trading	12.02.
T2 Biosystems Gets FDA Clearance for Expanded T2Bacteria Panel; Shares Rise	12.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen T2 Biosystems, Inc.

Aktien

A3EU63

US89853L3024

TTOO

Andere Sprachen

Filter